Patents by Inventor Michael Schumacher

Michael Schumacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11723911
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: August 15, 2023
    Assignee: M ET P PHARMA AG
    Inventors: Claudia Mattern, Elisabeth Traiffort, Michael Schumacher
  • Patent number: 11704259
    Abstract: A method for transferring packets of a communication protocol via a memory-based interface between two processing units. The method includes providing, in each of the processing units, a send area including a read index section, a write index section, and a send buffer, and a receive area including a read index section, a write index section and a receive buffer. Each processing unit repeats as sending steps: reading a read index from the receive area; writing at least one send packet into the send buffer (from a starting write address to an ending write address, the ending write address maximally corresponding to a buffer address assigned to the read read index, and writing a changed write index into the send area.
    Type: Grant
    Filed: October 22, 2021
    Date of Patent: July 18, 2023
    Assignee: ROBERT BOSCH GMBH
    Inventors: Andreas Karasek, Arvid Sievert, Guenter Dankl, Marc Zahnlecker, Marco Neumann, Claus-Michael Schumacher
  • Patent number: 11524055
    Abstract: Provided herein are methods and compositions for treating disease-states associated with presence of increased number of ErbB4+ pro-inflammatory macrophages in a subject in need thereof. The methods include providing an activator of ErbB4 and administering a therapeutically effective amount of the activator to the subject. The compositions include an activator of ErbB4. In one embodiment, the activation of ErbB4 is Neuregulin-4.
    Type: Grant
    Filed: May 26, 2020
    Date of Patent: December 13, 2022
    Assignee: Children's Hospital Los Angeles
    Inventors: Mark R. Frey, Michael Schumacher
  • Publication number: 20220138119
    Abstract: A method for transferring packets of a communication protocol via a memory-based interface between two processing units. The method includes providing, in each of the processing units, a send area including a read index section, a write index section, and a send buffer, and a receive area including a read index section, a write index section and a receive buffer. Each processing unit repeats as sending steps: reading a read index from the receive area; writing at least one send packet into the send buffer (from a starting write address to an ending write address, the ending write address maximally corresponding to a buffer address assigned to the read read index, and writing a changed write index into the send area.
    Type: Application
    Filed: October 22, 2021
    Publication date: May 5, 2022
    Inventors: Andreas Karasek, Arvid Sievert, Guenter Dankl, Marc Zahnlecker, Marco Neumann, Claus-Michael Schumacher
  • Publication number: 20220023765
    Abstract: Implementations described and claimed herein provide systems and methods for delivering a customizable feedback stimulus. In one implementation, a custom feedback device comprises a shell housing having a first shell and a second shell. The shell housing opening extends between an outer surface of the first shell and an outer surface of the second shell. A plurality of protrusions extends between the first shell and the second shell, and at least one receiving area is defined by the plurality of protrusions between the first shell and the second shell. The receiving area is adapted to house a customized portion.
    Type: Application
    Filed: August 5, 2021
    Publication date: January 27, 2022
    Inventors: Michael Schumacher, Philip Rowe
  • Publication number: 20210283143
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Application
    Filed: January 25, 2021
    Publication date: September 16, 2021
    Applicant: M ET P PHARMA AG
    Inventors: Claudia MATTERN, Elisabeth TRAIFFORT, Michael SCHUMACHER
  • Patent number: 11110361
    Abstract: Implementations described and claimed herein provide systems and methods for delivering a customizable feedback stimulus. In one implementation, a custom feedback device comprises a shell housing having a first shell and a second shell. The shell housing opening extends between an outer surface of the first shell and an outer surface of the second shell. A plurality of protrusions extends between the first shell and the second shell, and at least one receiving area is defined by the plurality of protrusions between the first shell and the second shell. The receiving area is adapted to house a customized portion.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: September 7, 2021
    Assignee: LAUGHABLE TOYS, LLC
    Inventors: Michael Schumacher, Philip Rowe
  • Patent number: 10898495
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: January 26, 2021
    Assignee: M ET P PHARMA AG
    Inventors: Claudia Mattern, Elisabeth Traiffort, Michael Schumacher
  • Publication number: 20200353043
    Abstract: Provided herein are methods and compositions for treating disease-states associated with presence of increased number of ErbB4+ pro-inflammatory macrophages in a subject in need thereof. The methods include providing an activator of ErbB4 and administering a therapeutically effective amount of the activator to the subject. The compositions include an activator of ErbB4. In one embodiment, the activation of ErbB4 is Neuregulin-4.
    Type: Application
    Filed: May 26, 2020
    Publication date: November 12, 2020
    Applicant: Children's Hospital Los Angeles
    Inventors: Mark R. Frey, Michael Schumacher
  • Patent number: 10800271
    Abstract: A supply device for a motor vehicle has a DC/DC converter and a control device for the DC/DC converter. The DC/DC converter has first terminals and second terminals, which first terminals are configured for electrical connection to a first energy storage or a first energy source and which second terminals are configured for electrical connection to a second energy storage or a load. The DC/DC converter is configured, in a first state to enable a conversion of a first DC voltage at the first terminals into a lower second DC voltage at the second terminals and, in a second state, to carry out no conversion of a first DC voltage at the first terminals into a lower second DC voltage at the second terminals. The control device enables an energy supply at the second terminals by repeatedly changing the DC/DC converter between the first state and the second state.
    Type: Grant
    Filed: January 14, 2019
    Date of Patent: October 13, 2020
    Assignee: Dr. Ing. h.c. F. Porsche Aktiengesellschaft
    Inventors: Christian Vienken, Dominique Labonte, Ulrich Steinhorst, Marc Thele, Michael Schumacher
  • Patent number: 10702586
    Abstract: Provided herein are methods and compositions for treating disease-states associated with presence of increased number of ErbB4+ pro-inflammatory macrophages in a subject in need thereof. The methods include providing an activator of ErbB4 and administering a therapeutically effective amount of the activator to the subject. The compositions include an activator of ErbB4. In one embodiment, the activation of ErbB4 is Neuregulin-4.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: July 7, 2020
    Assignee: Children's Hospital Los Angeles
    Inventors: Mark R. Frey, Michael Schumacher
  • Publication number: 20200206244
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Application
    Filed: March 11, 2020
    Publication date: July 2, 2020
    Applicant: M ET P PHARMA AG
    Inventors: Claudia MATTERN, Elisabeth TRAIFFORT, Michael SCHUMACHER
  • Patent number: 10596181
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Grant
    Filed: July 9, 2019
    Date of Patent: March 24, 2020
    Assignee: M ET P PHARMA AG
    Inventors: Claudia Mattern, Elisabeth Traiffort, Michael Schumacher
  • Publication number: 20200016501
    Abstract: Implementations described and claimed herein provide systems and methods for delivering a customizable feedback stimulus. In one implementation, a custom feedback device comprises a shell housing having a first shell and a second shell. The shell housing opening extends between an outer surface of the first shell and an outer surface of the second shell. A plurality of protrusions extends between the first shell and the second shell, and at least one receiving area is defined by the plurality of protrusions between the first shell and the second shell. The receiving area is adapted to house a customized portion.
    Type: Application
    Filed: July 23, 2019
    Publication date: January 16, 2020
    Applicant: Laughable Toys, LLC
    Inventors: Michael Schumacher, Philip Rowe
  • Publication number: 20190328750
    Abstract: Described herein are methods of promoting remyelination in a subject suffering from demyelination diseases by administering to the subject a combination of steroid hormones and Hedgehog signaling pathway modulators. Also described are methods of administering the combination of drugs, wherein the combination of drugs are in compositions adapted for nasal administration.
    Type: Application
    Filed: July 9, 2019
    Publication date: October 31, 2019
    Applicant: MET P PHARMA AG
    Inventors: Claudia MATTERN, Elisabeth TRAIFFORT, Michael SCHUMACHER
  • Patent number: 10415914
    Abstract: The invention relates to a shot counter for a firearm, which comprises a first magnetic pole, a second magnetic pole, and a coil. The first magnetic pole and the second magnetic pole have a polarization opposite to each other. The first magnetic pole and the second magnetic pole are configured to pass in response to a fired shot the coil one after the other along the track and to induce in the coil a voltage.
    Type: Grant
    Filed: December 29, 2017
    Date of Patent: September 17, 2019
    Assignee: HECKLER & KOCH GmbH
    Inventors: Ingo Lamparter, Frank Scheuermann, Michael Schumacher
  • Patent number: D873925
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: January 28, 2020
    Assignee: LAUGHABLE TOYS, LLC
    Inventors: Michael Schumacher, Dominic Lovely
  • Patent number: D909771
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: February 9, 2021
    Assignee: Laughable Toys, LLC
    Inventors: Michael Schumacher, Dominic Lovely
  • Patent number: D926257
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: July 27, 2021
    Assignee: LAUGHABLE TOYS, LLC
    Inventors: Michael Schumacher, Dominic Lovely
  • Patent number: D970233
    Type: Grant
    Filed: February 8, 2021
    Date of Patent: November 22, 2022
    Assignee: LAUGHABLE TOYS, LLC
    Inventors: Michael Schumacher, Dominic Lovely